Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Apogenix receives regulatory approval in Russia for phase II study of asunercept in COVID-19

July 30, 2020

Screening in serum yields potential antibiotics against drug-resistant K. pneumoniae

July 30, 2020

COVACTA trial of Actemra in severe COVID-19-associated pneumonia misses endpoints

July 29, 2020

European Commission grants approval for Xenleta as treatment of CAP

July 29, 2020

Reata announces investigator-sponsored trial of bardoxolone in patients with COVID-19

July 29, 2020

Series A financing to support ExeVir's development of VHH-72-Fc for COVID-19

July 29, 2020

AHR inhibition suppresses Zika infection

July 29, 2020

Pfizer and BioNTech advance BNT-162b2 into pivotal study for COVID-19

July 28, 2020

Can-Fite submits IND application for phase II study of piclidenoson for COVID-19

July 28, 2020

PDS Biotech reports preclinical data for PDS-0203

July 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...